A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011
Non-Barbiturate, Drug-Induced Reversible Loss of Brainstem Reflexes
Neurol 51:639-640, Richard,I.H.,et al, 1998
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995
Myoclonus Associated with Propafenone
BMJ 308:113, Chua,T.P.,et al, 1994
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
Diaphragmatic Paralysis
Am J Med 86:623-624, Javaheri,S.,et al, 1989
"Doom Anxiety"and Delirium in Lidocaine Toxicity
Am J Psychiatry 144:159-163, Saravay,S.M.,et al, 1987
Unusual Neurotoxicity Associated with Amiodarone Therapy
Arch Int Med 147:881-884, Palakurthy,P.R.,et al, 1987
Embolic Complications in Paroxysmal Atrial Fibrillation
Stroke 17:622-626, Petersen,P.&Godtfredsen,J., 1986
Tocainide Encephalopathy
Neurol 35:1804-1805, Vincent,F.M., 1985
Neuropathy & Fatal Hepatitis in a Patient Receiving Amiodarone
BMJ 288:1638-1639, Lim,P.K.,et al, 1984
Procainamide-Induced Myasthenia-like Weakness in a Patient with Peripheral Neuropathy
Arch Neurol 38:378-379, Niakan,E.,et al, 1981